Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study
- PMID: 35943274
- PMCID: PMC9431624
- DOI: 10.1128/spectrum.02473-21
Improving Suspected Pulmonary Infection Diagnosis by Bronchoalveolar Lavage Fluid Metagenomic Next-Generation Sequencing: a Multicenter Retrospective Study
Abstract
Metagenomic next-generation sequencing (mNGS) has been gradually applied to clinical practice due to its unbiased characteristics of pathogen detection. However, its diagnostic performance and clinical value in suspected pulmonary infection need to be evaluated. We systematically reviewed the clinical data of 246 patients with suspected pulmonary infection from 4 medical institutions between January 2019 and September 2021. The diagnostic performances of mNGS and conventional testing (CT) were systematically analyzed based on bronchoalveolar lavage fluid (BALF). The impacts of mNGS and CT on diagnosis modification and treatment adjustment were also assessed. The positive rates of mNGS and CT were 47.97% and 23.17%, respectively. The sensitivity of mNGS was significantly higher than that of CT (53.49% versus 23.26%, P < 0.01), especially for infections of Mycobacterium tuberculosis (67.86% versus 17.86%, P < 0.01), atypical pathogens (100.00% versus 7.14%, P < 0.01), viruses (92.31% versus 7.69%, P < 0.01), and fungi (78.57% versus 39.29%, P < 0.01). The specificity of mNGS was superior to that of CT, with no statistical difference (90.32% versus 77.42%, P = 0.167). The positive predictive value (PPV) and negative predictive value (NPV) of mNGS were 97.46% and 21.88%, respectively. Diagnosis modification and treatment adjustment were conducted in 32 (32/246, 13.01%) and 23 (23/246, 9.35%) cases, respectively, according to mNGS results only. mNGS significantly improved the diagnosis of suspected pulmonary infection, especially infections of M. tuberculosis, atypical pathogens, viruses, and fungi, and it demonstrated the pathogen distribution of pulmonary infections. It is expected to be a promising microbiological detection and diagnostic method in clinical practice. IMPORTANCE Pulmonary infection is a heterogeneous and complex infectious disease with high morbidity and mortality worldwide. In clinical practice, a considerable proportion of the etiology of pulmonary infection is unclear, microbiological diagnosis being challenging. Metagenomic next-generation sequencing detects all nucleic acids in a sample in an unbiased manner, revealing the microbial community environment and organisms and improving the microbiological detection and diagnosis of infectious diseases in clinical settings. This study is the first multicenter, large-scale retrospective study based entirely on BALF for pathogen detection by mNGS, and it demonstrated the superior performance of mNGS for microbiological detection and diagnosis of suspected pulmonary infection, especially in infections of Mycobacterium tuberculosis, atypical pathogens, viruses, and fungi. It also demonstrated the pathogen distribution of pulmonary infections in the real world, guiding targeted treatment and improving clinical management and prognoses.
Keywords: BALF; mNGS; pathogen; pulmonary infection.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
Diagnostic value of metagenomic next-generation sequencing of bronchoalveolar lavage fluid for the diagnosis of suspected pneumonia in immunocompromised patients.BMC Infect Dis. 2022 Apr 29;22(1):416. doi: 10.1186/s12879-022-07381-8. BMC Infect Dis. 2022. PMID: 35488253 Free PMC article.
-
Metagenomic next-generation sequencing indicates more precise pathogens in patients with pulmonary infection: A retrospective study.Front Cell Infect Microbiol. 2022 Oct 7;12:977591. doi: 10.3389/fcimb.2022.977591. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36275015 Free PMC article.
-
Diagnostic value of metagenomic next-generation sequencing using bronchoalveolar lavage fluid samples for pathogen detection in children with severe or refractory pneumonia.Microbiol Spectr. 2025 Mar 4;13(3):e0108724. doi: 10.1128/spectrum.01087-24. Epub 2025 Feb 4. Microbiol Spectr. 2025. PMID: 39902982 Free PMC article.
-
Metagenomic next generation sequencing of bronchoalveolar lavage fluids for the identification of pathogens in patients with pulmonary infection: A retrospective study.Diagn Microbiol Infect Dis. 2024 Sep;110(1):116402. doi: 10.1016/j.diagmicrobio.2024.116402. Epub 2024 Jun 12. Diagn Microbiol Infect Dis. 2024. PMID: 38878340 Review.
-
The clinical application of metagenomic next-generation sequencing for detecting pathogens in bronchoalveolar lavage fluid: case reports and literature review.Expert Rev Mol Diagn. 2022 May;22(5):575-582. doi: 10.1080/14737159.2022.2071607. Epub 2022 May 2. Expert Rev Mol Diagn. 2022. PMID: 35473493 Review.
Cited by
-
An Investigation into Diagnostic Strategies for Central Nervous System Infections Through the Integration of Metagenomic Next-Generation Sequencing and Conventional Diagnostic Methods.Infect Drug Resist. 2024 Nov 5;17:4865-4873. doi: 10.2147/IDR.S483985. eCollection 2024. Infect Drug Resist. 2024. PMID: 39524979 Free PMC article.
-
The epidemiological characteristics of invasive pulmonary aspergillosis and risk factors for treatment failure: a retrospective study.BMC Pulm Med. 2024 Nov 8;24(1):559. doi: 10.1186/s12890-024-03381-3. BMC Pulm Med. 2024. PMID: 39511508 Free PMC article.
-
Diagnosis of acute Q fever using targeted next‑generation sequencing: A case report.Exp Ther Med. 2024 Nov 18;29(1):13. doi: 10.3892/etm.2024.12764. eCollection 2025 Jan. Exp Ther Med. 2024. PMID: 39624593 Free PMC article.
-
Torquetenovirus from bronchoalveolar lavage fluid as a biomarker for lung infection among immunocompromised hosts.Biomark Med. 2024;18(13-14):581-591. doi: 10.1080/17520363.2024.2366148. Epub 2024 Jul 9. Biomark Med. 2024. PMID: 38982729 Free PMC article.
-
Utilizing metagenomic next-generation sequencing for diagnosis and lung microbiome probing of pediatric pneumonia through bronchoalveolar lavage fluid in pediatric intensive care unit: results from a large real-world cohort.Front Cell Infect Microbiol. 2023 Aug 15;13:1200806. doi: 10.3389/fcimb.2023.1200806. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37655299 Free PMC article.
References
-
- Magill SS, Edwards JR, Bamberg W, Beldavs ZG, Dumyati G, Kainer MA, Lynfield R, Maloney M, McAllister-Hollod L, Nadle J, Ray SM, Thompson DL, Wilson LE, Fridkin SK. Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. 2014. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 370:1198–1208. doi:10.1056/NEJMoa1306801. - DOI - PMC - PubMed
-
- Jain S, Self WH, Wunderink RG, Fakhran S, Balk R, Bramley AM, Reed C, Grijalva CG, Anderson EJ, Courtney DM, Chappell JD, Qi C, Hart EM, Carroll F, Trabue C, Donnelly HK, Williams DJ, Zhu Y, Arnold SR, Ampofo K, Waterer GW, Levine M, Lindstrom S, Winchell JM, Katz JM, Erdman D, Schneider E, Hicks LA, McCullers JA, Pavia AT, Edwards KM, Finelli L. CDC EPIC Study Team. 2015. Community-acquired pneumonia requiring hospitalization among U.S. adults. N Engl J Med 373:415–427. doi:10.1056/NEJMoa1500245. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical